Literature DB >> 25282173

Potential lactoferrin activity against pathogenic viruses.

Elrashdy M Redwan1, Vladimir N Uversky2, Esmail M El-Fakharany3, Hussein Al-Mehdar4.   

Abstract

Lactoferrin (LF) is an 80-kDa globular glycoprotein with high affinity for metal ions, particularly for iron. This protein possesses many biological functions, including the binding and release of iron and serves as one of the important components of the innate immune system, where it acts as a potent inhibitor of several pathogens. LF has efficacious antibacterial and antiviral activities against a wide range of Gram-positive and Gram-negative bacteria and against both naked and enveloped DNA and RNA viruses. In its antiviral pursuit, LF acts predominantly at the acute phase of the viral infection or even at the intracellular stage, as in hepatitis C virus infection. LF inhibits the entry of viral particles into host cells, either by direct attachment to the viral particles or by blocking their cellular receptors. This wide range of activities may be attributed to the capacity of LF to bind iron and its ability to interfere with the cellular receptors of both hosts and pathogenic microbes.
Copyright © 2014 Académie des sciences. All rights reserved.

Entities:  

Keywords:  Antiviral activity; Lactoferrin; Pathogen

Mesh:

Substances:

Year:  2014        PMID: 25282173     DOI: 10.1016/j.crvi.2014.08.003

Source DB:  PubMed          Journal:  C R Biol        ISSN: 1631-0691            Impact factor:   1.583


  30 in total

1.  Synergistic Killing of Pathogenic Escherichia coli Using Camel Lactoferrin from Different Saudi Camel Clans and Various Antibiotics.

Authors:  Hussein A Almehdar; Nawal Abd El-Baky; Abdulqader A Alhaider; Saud A Almuhaideb; Abdullah A Alhaider; Raed S Albiheyri; Vladimir N Uversky; Elrashdy M Redwan
Journal:  Protein J       Date:  2019-08       Impact factor: 2.371

2.  Bacteriostatic and Bactericidal Activities of Camel Lactoferrins Against Salmonella enterica Serovar Typhi.

Authors:  Hussein A Almehdar; Nawal Abd El-Baky; Abdulqader A Alhaider; Saud A Almuhaideb; Abdullah A Alhaider; Raed S Albiheyri; Vladimir N Uversky; Elrashdy M Redwan
Journal:  Probiotics Antimicrob Proteins       Date:  2020-03       Impact factor: 4.609

3.  Entry Inhibitors of Hepatitis C Virus.

Authors:  Xi-Jing Qian; Zhong-Tian Qi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Investigating the Link between Alpha-1 Antitrypsin and Human Neutrophil Elastase in Bronchoalveolar Lavage Fluid of COVID-19 Patients.

Authors:  Maura D'Amato; Valentina Vertui; Laura Pandolfi; Sara Bozzini; Tommaso Fossali; Riccardo Colombo; Anna Aliberti; Marco Fumagalli; Paolo Iadarola; Camilla Didò; Simona Viglio; Federica Meloni
Journal:  Curr Issues Mol Biol       Date:  2022-05-10       Impact factor: 2.976

5.  Recombinant human lactoferrin carrying humanized glycosylation exhibits antileukemia selective cytotoxicity, microfilament disruption, cell cycle arrest, and apoptosis activities.

Authors:  Sayuri Nakamura-Bencomo; Denisse A Gutierrez; Elisa Robles-Escajeda; Blanca Iglesias-Figueroa; Tania S Siqueiros-Cendón; Edward A Espinoza-Sánchez; Sigifredo Arévalo-Gallegos; Renato J Aguilera; Quintín Rascón-Cruz; Armando Varela-Ramirez
Journal:  Invest New Drugs       Date:  2020-10-16       Impact factor: 3.850

6.  Efficacy of Lactoferrin with Standard Triple Therapy or Sequential Therapy for Helicobacter pylori Eradication: A Randomized Controlled Trial.

Authors:  Fahmy H Hablass; Sameh A Lashen; Eman A Alsayed
Journal:  Turk J Gastroenterol       Date:  2021-09       Impact factor: 1.555

Review 7.  Milk Proteins-Their Biological Activities and Use in Cosmetics and Dermatology.

Authors:  Kinga Kazimierska; Urszula Kalinowska-Lis
Journal:  Molecules       Date:  2021-05-28       Impact factor: 4.411

8.  Lactoferrin and Immunoglobulin Concentrations in Milk of Gestational Diabetic Mothers.

Authors:  Jolanta Lis-Kuberka; Marta Berghausen-Mazur; Magdalena Orczyk-Pawiłowicz
Journal:  Nutrients       Date:  2021-03-02       Impact factor: 5.717

Review 9.  The effects of orally administered lactoferrin in the prevention and management of viral infections: A systematic review.

Authors:  Alessandra Sinopoli; Claudia Isonne; Maria Mercedes Santoro; Valentina Baccolini
Journal:  Rev Med Virol       Date:  2021-05-28       Impact factor: 11.043

Review 10.  Entry inhibitors: New advances in HCV treatment.

Authors:  Xi-Jing Qian; Yong-Zhe Zhu; Ping Zhao; Zhong-Tian Qi
Journal:  Emerg Microbes Infect       Date:  2016-01-06       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.